CRP and hydrops fetalis: The residual CV risk has been associated with some clinical characteristics (diabetes, prior ACS, stroke, HF, poly-vascular disease, extent of CAD, completeness of revascularization) and biomarkers, such as troponins, N-terminal pro-B-type natriuretic peptide (NT-proBNP), and C-Reactive protein (CRP) [35].